Previous 10 | Next 10 |
home / stock / vvcif / vvcif news
VIVO Cannabis (TSX.V: VIVO) (OTCQX: VVCIF) , an Ontario-based cannabis company recognized for its premium products and services, this morning announced that it has granted, effective today, an aggregate of 3,364,500 stock options (each, an "Option") to certain directors, officers, employees a...
VIVO Announces Stock Option Grants Canada NewsWire NAPANEE, ON, Dec. 12, 2019 NAPANEE, ON , Dec. 12, 2019 /CNW/ - VIVO Cannabis Inc. (TSX-V: VIVO, OTCQX: VVCIF) (" VIVO " or the " Company ") today announced that it has granted, effective today, an aggregate of 3,36...
Let’s talk a little about cannabidiol (CBD). You have undoubtedly heard of the hemp extract, famous as it is these days. The cannabidiol market was already worth at least one billion by the end of 2018, and experts say it could grow to more than $20 billion by 2026. Last year, CBD gummi...
The holiday season is around the corner, and it is a time of festivities and gathering of families, friends, and relatives. To some, the season is a source of stress, anxiety, and insomnia. Are you nervous when attending a family gathering? Take a small dose of marijuana to take the edge off. ...
This has got to be the best decade for cannabis. Whether it’s for recreational or medical use, the controversial plant has endeared itself to many. Cannabidiol (CBD) is one of the over 100 cannabinoids present in the cannabis plant, and it is responsible for much of the hype around cann...
This week, former Colorado public officials Stanley Garnett and Doug Friednash, who were opposed to marijuana legalization, shared their opinions with Minnesota legislators about the things to consider if cannabis is to be legalized. The two are currently members of a Denver law firm with a ...
Alnylam Pharmaceuticals (NASDAQ: ALNY ) initiated with Outperform rating and $128 (31% upside) price target at Oppenheimer. More news on: Alnylam Pharmaceuticals, Inc., Amarin Corporation plc, CytomX Therapeutics, Inc., Healthcare stocks news, Stocks on the move, , Read more ...
The following slide deck was published by VIVO Cannabis Inc. in conjunction with this Read more ...
VIVO Cannabis Inc. (VVCIF) Q3 2019 Earnings Conference Call November 15, 2019 10:00 A.M. ET Company Participants Barry Fishman - Chief Executive Officer Michael Bumby - Chief Financial Officer Conference Call Participants Kimberly Hedlin - Canaccord Genuity Presentation ...
Cannabidiol (CBD) has been having a magnificent run for the past couple of years. The cannabis extract is, without a doubt, one of the most versatile and potent naturally-occurring medicines we’ve encountered in decades, if not centuries. Said to be effective against a variety of medica...
News, Short Squeeze, Breakout and More Instantly...
MediPharm Labs Corp. Completes Acquisition of VIVO Cannabis Inc. and Confirms Final Ownership Ratio Canada NewsWire BARRIE, ON , April 3, 2023 /CNW/ - MediPharm Labs Corp . (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) ("MediPharm", or "MediPharm Labs") and VIVO Ca...
Net revenue for Q4 2022 was $7.1 million, a 15% increase from prior quarter. Net revenue for 2022 was $25.4 million, a 2% increase compared to 2021. Net losses have decreased by 21.2 million in 2022, a 30% decrease from the prior year. The Company signed a definitive agreemen...
Toronto, Ontario--(Newsfile Corp. - March 24, 2023) - VIVO Cannabis Inc. (TSX: VIVO) (OTCQB: VVCIF) (" VIVO ") is pleased to announce that it has obtained a final court order (the " Final Order ") from the Ontario Superior Court of Justice (Commercial List) approving the previously announced pl...